uracil has been researched along with Gallbladder Neoplasms in 12 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Gallbladder Neoplasms: Tumors or cancer of the gallbladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 9.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| "Standard chemotherapy for advanced biliary tract cancer has not been established." | 6.72 | Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. ( Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K, 2006) |
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 5.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| "Four patients with gallbladder cancer and two with bile duct cancer were treated with mitomycin C, carboquone, 5-fluorouracil and OK-432 (MQF-OK therapy) plus tegafur (FT) or UFT." | 3.67 | [MQF-FT and MQF-UFT in gallbladder and bile duct cancer]. ( Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K, 1988) |
| "Standard chemotherapy for advanced biliary tract cancer has not been established." | 2.72 | Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. ( Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K, 2006) |
| "A 69 -year-old female with advanced gallbladder cancer underwent cholecystectomy, S4a/S5 segmentectomy of the liver, and resection of the extra-hepatic bile duct in October 2005." | 1.40 | [A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy]. ( Karasawa, H; Katagiri, M; Katayose, Y; Morikawa, T; Motoi, F; Naito, T; Sato, J; Unno, M; Yabuuchi, S, 2014) |
| "A 67-year-old man with gallbladder cancer was treated by cholecystectomy and extrahepatic bile duct resection with regional lymph node dissection." | 1.32 | [A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy]. ( Kido, S; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Motoyama, K; Takei, M, 2003) |
| "The prognosis of unresectable advanced gallbladder cancer is extremely poor." | 1.32 | [A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer]. ( Dono, K; Hashimoto, K; Kubota, M; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Takahashi, H; Umeshita, K; Yamamoto, S, 2004) |
| "A 64-year-old women with gallbladder cancer was treated by extended cholecystectomy and regional lymph node dissection." | 1.29 | [A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy]. ( Arima, S; Futami, K; Kotoh, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katagiri, M | 1 |
| Katayose, Y | 1 |
| Yabuuchi, S | 1 |
| Karasawa, H | 1 |
| Sato, J | 1 |
| Morikawa, T | 1 |
| Motoi, F | 1 |
| Naito, T | 1 |
| Unno, M | 1 |
| Furuse, J | 2 |
| Okusaka, T | 2 |
| Ohkawa, S | 1 |
| Nagase, M | 2 |
| Funakoshi, A | 2 |
| Boku, N | 1 |
| Yamao, K | 2 |
| Yamaguchi, T | 1 |
| Sato, T | 1 |
| González, ME | 1 |
| Giannini, OH | 1 |
| González, P | 1 |
| Saldaña, B | 1 |
| Matsuyama, S | 1 |
| Takei, M | 1 |
| Kido, S | 1 |
| Magata, S | 1 |
| Motoyama, K | 1 |
| Kitahara, K | 1 |
| Miyazaki, K | 1 |
| Marubashi, S | 1 |
| Dono, K | 1 |
| Takahashi, H | 1 |
| Hashimoto, K | 1 |
| Kubota, M | 1 |
| Yamamoto, S | 1 |
| Miyamoto, A | 1 |
| Nagano, H | 1 |
| Nakamori, S | 1 |
| Umeshita, K | 1 |
| Sakon, M | 1 |
| Monden, M | 1 |
| Soma, I | 1 |
| Hasuike, Y | 1 |
| Hayashi, N | 1 |
| Fukuchi, N | 1 |
| Izawa, H | 1 |
| Yoshida, T | 1 |
| Ebisui, C | 1 |
| Sakita, I | 1 |
| Fujimoto, T | 1 |
| Koshino, T | 1 |
| Izumiyama, K | 1 |
| Kimura, M | 2 |
| Inoue, M | 1 |
| Morisaki, T | 1 |
| Kaneda, H | 1 |
| Kume, S | 1 |
| Matsushita, H | 1 |
| Horino, K | 1 |
| Nishimura, T | 1 |
| Arima, T | 1 |
| Uemura, K | 1 |
| Ishii, H | 1 |
| Nakachi, K | 1 |
| Ueno, H | 1 |
| Ikeda, M | 1 |
| Morizane, C | 1 |
| Horikawa, Y | 1 |
| Mizuno, N | 1 |
| Kotoh, T | 1 |
| Arima, S | 1 |
| Futami, K | 1 |
| Kawabata, Y | 1 |
| Yano, S | 1 |
| Ohishi, T | 1 |
| Sumi, S | 1 |
| Nio, Y | 1 |
| Tamura, K | 1 |
| Mani, S | 1 |
| Sciortino, D | 1 |
| Samuels, B | 1 |
| Arrietta, R | 1 |
| Schilsky, RL | 1 |
| Vokes, EE | 1 |
| Benner, S | 1 |
| Sakata, Y | 1 |
| Fukushi, G | 1 |
| Tsushima, K | 1 |
| Suzuki, H | 1 |
| Kimura, T | 1 |
| Tamura, Y | 1 |
| Kishibe, T | 1 |
| Saitoh, S | 1 |
| Itoh, T | 1 |
3 trials available for uracil and Gallbladder Neoplasms
| Article | Year |
|---|---|
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Du | 2009 |
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2006 |
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Female; Gallbladder Neopl | 1999 |
9 other studies available for uracil and Gallbladder Neoplasms
| Article | Year |
|---|---|
[A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2014 |
Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Capec | 2011 |
[A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Ducts, Extrahepatic; Cholecystectomy; Drug Adminis | 2003 |
[A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Female; Fluor | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined | 2004 |
[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Fem | 2005 |
[A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Gallbladder Neopl | 1994 |
[A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 1999 |
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Car | 1988 |